Biomm

Biomm ROA

The Return on Assets (ROA) of Biomm (BIOM3.SA) as of Nov 16, 2026 is -1.28 %. In the previous year, Return on Assets (ROA) was -16.59 % — a change of -92.31% (higher).

ROA

-1.28 %

YoY

-92.31%

Last updated:

In 2025, Biomm's return on assets (ROA) was -1.28 %, a -92.31% increase from the -16.59 % ROA in the previous year.

The Biomm ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-13.92 BRL
Jan 1, 2019
-14.36 BRL
Jan 1, 2020
-16.27 BRL
Jan 1, 2021
-21.70 BRL
Jan 1, 2022
-22.85 BRL
Jan 1, 2023
-23.54 BRL
Jan 1, 2024
-16.59 BRL
Jan 1, 2025
-1.28 BRL
The Biomm ROA history
YEARROAYoY
-1.28 %-92.31%
-16.59 %-29.54%
-23.54 %+3.02%
-22.85 %+5.28%
-21.70 %+33.39%
-16.27 %+13.33%
-14.36 %+3.11%
-13.92 %-4.18%
-14.53 %-24.37%
-19.21 %-632.80%
3.61 %-150.93%
-7.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biomm Stock analysis

What does Biomm do? Biomm SA generates revenue through the development and licensing of technology for producing human insulin and other recombinant proteins. The company's patented technology, protected in multiple regions, is used by pharmaceutical firms to manufacture therapeutic proteins for drugs and biopharmaceuticals. Its subsidiaries Biomm International Inc, Biomm Middle East Inc, and Biomm Russia Ltd support global operations. The firm also develops production processes for enzymes used in biomass hydrolysis and bio-fuel manufacturing, targeting industrial applications in renewable energy sectors. The primary buyers of Biomm SA's technology are pharmaceutical companies seeking to produce therapeutic proteins. These firms license the company's patented insulin production methods to integrate into their drug manufacturing processes. The enzyme production technology is sold to companies in the bio-fuel industry, particularly those involved in biomass conversion for renewable energy. Biomm SA's focus on recombinant protein production and bio-fuel applications positions it within the biotechnology and renewable energy markets. The company's business model relies on technology licensing fees and sales of proprietary production processes. Insulin production technology, protected by international patents, forms a significant revenue stream. Enzyme technology for biomass hydrolysis and bio-fuel manufacturing provides additional income from industrial clients. Biomm SA's subsidiaries facilitate international market access, enabling the company to serve global clients across pharmaceutical and renewable energy sectors. Biomm is one of the most popular companies on Eulerpool.

ROA Details

Understanding Biomm's Return on Assets (ROA)

Biomm's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biomm's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biomm's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biomm’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biomm stock

Return on Assets (ROA) of Biomm is -1.28 % in 2025.

Return on Assets (ROA) of Biomm changed from -16.59 % to -1.28 %, representing a -92.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Biomm since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Biomm with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biomm

All Key Metrics — Biomm